《关于“利用计算机模拟方法重新利用FDA批准的药物对抗COVID-19：通过虚拟筛选和分子动力学模拟靶向SARS-CoV-2 RdRp酶和宿主细胞受体（ACE2、CD147）”的勘误》[《信息医学未锁定》23（2021）1-9/100541]
Corrigendum to ‟Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulationsˮ [Inform. Med. Unlocked 23 (2021) 1-9/100541].
作者信息
Mahdian Soodeh, Zarrabi Mahboobeh, Panahi Yunes, Dabbagh Sadeghpour Somayyeh
机构信息
Department of Cellular and Molecular Biology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran.
Department of Biotechnology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran.
出版信息
Inform Med Unlocked. 2023 May 4:101263. doi: 10.1016/j.imu.2023.101263.
Abstract
[This corrects the article DOI: 10.1016/j.imu.2021.100541.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.imu.2021.100541。]
相似文献
1
Corrigendum to ‟Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulationsˮ [Inform. Med. Unlocked 23 (2021) 1-9/100541].《关于“利用计算机模拟方法重新利用FDA批准的药物对抗COVID-19：通过虚拟筛选和分子动力学模拟靶向SARS-CoV-2 RdRp酶和宿主细胞受体（ACE2、CD147）”的勘误》[《信息医学未锁定》23（2021）1-9/100541]
Inform Med Unlocked. 2023 May 4:101263. doi: 10.1016/j.imu.2023.101263.
2
Repurposing FDA-approved drugs to fight COVID-19 using methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations.利用以下方法将美国食品药品监督管理局（FDA）批准的药物重新用于抗击新冠病毒：通过虚拟筛选和分子动力学模拟靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的RNA依赖性RNA聚合酶（RdRp）酶和宿主细胞受体（血管紧张素转换酶2（ACE2）、CD147）。
Inform Med Unlocked. 2021;23:100541. doi: 10.1016/j.imu.2021.100541. Epub 2021 Feb 25.
3
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.靶向 TMPRSS2 和 ACE2 的 SARS-CoV-2 进入抑制剂：一种计算机药物重定位研究。
Eur J Pharmacol. 2021 Apr 5;896:173922. doi: 10.1016/j.ejphar.2021.173922. Epub 2021 Feb 2.
4
Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review.针对 RNA 依赖性 RNA 聚合酶的 COVID-19 潜在靶点：全面综述。
Curr Pharm Biotechnol. 2022;23(3):396-419. doi: 10.2174/1389201022666210421102513.
5
Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.基于结构的虚拟筛选、分子动力学模拟和 MM-PBSA 方法对 B.1.617.2（德尔塔）、AY.1（德尔塔加）和 C.37（拉姆达）SARS-CoV-2 变异株关键刺突突变进行计算重利用的方法。
Comput Biol Med. 2022 Aug;147:105709. doi: 10.1016/j.compbiomed.2022.105709. Epub 2022 Jun 7.
6
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection.防治 SARS-CoV-2（COVID-19）感染的当前靶点和药物候选物。
Rev Cardiovasc Med. 2020 Sep 30;21(3):365-384. doi: 10.31083/j.rcm.2020.03.118.
7
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an perspective.靶向 SARS-CoV-2 RNA 依赖性 RNA 聚合酶（RdRp）：一个研究视角。
J Biomol Struct Dyn. 2021 Jun;39(9):3204-3212. doi: 10.1080/07391102.2020.1761882. Epub 2020 May 6.
8
Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective.将美国食品药品监督管理局（FDA）批准的药物西替利司他、阿比特龙、二碘羟基喹啉、贝沙罗汀和瑞德西韦重新用作针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的RNA依赖性RNA聚合酶的潜在抑制剂：一项计算机模拟比较研究。
Inform Med Unlocked. 2023;36:101147. doi: 10.1016/j.imu.2022.101147. Epub 2022 Dec 8.
9
Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.针对血管紧张素转化酶 2（ACE2）受体的不同化合物可能含有 SARS-CoV-2 的感染力：一项计算机研究。
J Mol Model. 2022 Mar 5;28(4):82. doi: 10.1007/s00894-022-05059-1.
10
Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.重新利用非核苷类抗病毒药物治疗 SARS-CoV2 NSP12（RNA 依赖性 RNA 聚合酶）：计算机分子洞察。
Biochem Biophys Res Commun. 2021 Sep 24;571:26-31. doi: 10.1016/j.bbrc.2021.07.050. Epub 2021 Jul 16.
Zotero 插件